Concepedia
Statistics
Publications
35
Citations
1.6K
H-Index
22
Active since
2007
Affiliations
Eli Lilly (United States)(Current)
Alkermes (United States)
Alkermes (Ireland)
Zucker Hillside Hospital
Eli Lilly (United Kingdom)
David McDonnell is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and pharmacology.
Top concepts
MedicinePsychiatryPharmacologySchizophreniaPharmacotherapyPsychopharmacologyPsychopathologySocial SciencesNeuropharmacologyMood Disorders
Publications per year
2007–2023
Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
John M. Kane, Holland C. Detke, Dieter Naber et al. · American Journal of Psychiatry · 2009 · 196 citations
Dose correspondence between olanzapine long-acting injection and oral olanzapine
Holland C. Detke, Fangyi Zhao, Parag Garhyan et al. · International Clinical Psychopharmacology · 2010 · 184 citations
Olanzapine Long-acting Injection, Oral Olanzapine, Psychiatry +13
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
Mauricio Tohen, David McDonnell, Michael Case et al. · The British Journal of Psychiatry · 2012 · 126 citations · Full text
An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
John Lauriello, Tim Lambert, Scott W. Andersen et al. · The Journal of Clinical Psychiatry · 2008 · 119 citations
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study
Christoph U. Correll, John W. Newcomer, Bernard L. Silverman et al. · American Journal of Psychiatry · 2020 · 116 citations
1–5 of 35